trial
as of 2026-07-01Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial
NCTId NCT07342764
at a glance
Phase 4 · Not Yet Recruiting
Enrollment 110 (estimated)
Sponsored by Sultan Qaboos University
Primary completion 2028-11
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Not Yet Recruiting
Enrollment
110 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2026-09
Primary completion
2028-11
Eligibility
ALL · 16 Years · 60 Years
Interventions & indications
Sponsors
Sultan Qaboos UniversityLead Sponsor
Investigators
1
Mohammed Al Alawi, MD, PhDStudy Chair
Sites
1 total
Muscat, Oman
Facts & assertions
4 sourced
Enrollment
110
Phase
PHASE4
Primary Completion Date
2028-11
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
lead_sponsor
company
indication
indication
indication
indication
investigator